Motley Fool: 3 Drug Stocks With Unimaginably Low P/E Ratios

Arguably one of the toughest things to do as an investor is find value in a stock market that continues to hit new highs. Of course, value is in the eye of the beholder, and there are more metrics that…

Advertisements

Motley Fool: 3 Top Value Stocks to Buy in July

Value stocks aren’t easy to find these days. The market is hitting all-time highs nearly every single day it seems, and the S&P 500 and Dow Jones Industrial Average have both hit new milestones in recent days, at 3,000 and…

Motley Fool: Here’s Why Generic-Drug Manufacturers Lost As Much As 43.2% in May

What happened Last month was one to forget for the generic-drug industry, which was confronted head-on by a sweeping lawsuit from dozens of states alleging conspiracy to fix drug prices. Shares of nearly every company with ties to generic-drug manufacturing…

Motley Fool: Here’s Why Teva Pharmaceuticals Is Sinking Today

What happened Shares of Teva Pharmaceutical Industries (NYSE:TEVA) fell over 11% today after the company announced it had agreed to pay $85 million to the state of Oklahoma for its role in the American opioid crisis. While the business can…

Motley Fool: 3 Top Large-Cap Stocks to Buy in September

The stock market’s reaching new highs, and that has people wondering how long it will be before profit-takers cause a sell-off. There’s no telling what the market may do in the short term, but our Fools think this is a…